Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 26, 2020BiomoleculesOpen Access

Precision Medicine for Lysosomal Disorders

View Full Paper
Ask AI
Bookmark
Share

Authors

FVFilippo Pinto e VairoMayo ClinicDMDiana Rojas MálagaUniversidade Federal do Rio Grande do SulFKFrancyne KubaskiUniversidade Federal do Rio Grande do Sul

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Vairo et al. (2020) studied this question.

synapsesocial.com/papers/6a7c889165565e044576df07https://doi.org/10.3390/biom10081110
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Duvoglustat HCl Increases Systemic and Tissue Exposure of Active Acid α-Glucosidase in Pompe Patients Co-administered with Alglucosidase α2017 · 46 citations
  2. 2Quality of life of Hurler syndrome patients after successful hematopoietic stem cell transplantation2017 · 29 citations
  3. 3A probable new syndrome with the storage disease phenotype caused by the VPS33A gene mutation2016 · 39 citations
  4. 4Safety of Intradiaphragmatic Delivery of Adeno-Associated Virus-Mediated Alpha-Glucosidase (rAAV1-CMV- hGAA ) Gene Therapy in Children Affected by Pompe Disease2017 · 121 citations